Prepare for your visit
Kelly E Goodwin
Adult Health (Nurse Practitioner) · Franklin, MA · NPI 1093006884
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$14,455.47
in general payments reported to CMS, 2019-2025 · $845 in 2025
The $845 reported for 2025 was more than what 82% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Who reported paying
General payments only, top 5 by amount.
- Takeda Pharmaceuticals U.S.A., INC. $7,692.50
- Pfizer INC. $3,700.00
- Janssen Biotech, INC. $2,217.98
- Nuvation Bio INC. $720.00
- Astrazeneca Pharmaceuticals LP $124.99
Drugs and devices associated with these payments
Braftovi Vizimpro Mektovi Lorbrena Rybrevant Exkivity Ibtrozi Wainua
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Kelly Goodwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10782372/kelly-e-goodwin